The goal of this research study is to evaluate how well and safely the study drugs sasanlimab, palbociclib, and axitinib work for treatment of participants wit…

Metastatic Renal Cell CarcinomaMetastatic Renal CancerRenal Cell Carcinoma+3 more

~Estimated

~$10 – $7,500

Stephanie BergNCT07123090

Phase 1

A Phase 1b/2 Study of Abemaciclib Plus Cabozantinib in Immune Checkpoint Blockade-pretreated Metastatic Clear Cell Renal Cell Carcinoma

The researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with meta…

Metastatic Renal Cell CarcinomaTranslocation Renal Cell Carcinoma

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT06835972